SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $360,150 | -65.7% | 17,500 | -30.0% | 0.00% | -66.7% |
Q1 2023 | $1,049,000 | -50.4% | 25,000 | -55.0% | 0.01% | -40.0% |
Q4 2022 | $2,116,770 | +77.3% | 55,500 | +82.0% | 0.01% | +66.7% |
Q3 2022 | $1,194,000 | +28.7% | 30,500 | +6.1% | 0.01% | +50.0% |
Q2 2022 | $928,000 | -42.0% | 28,740 | -40.5% | 0.00% | -33.3% |
Q1 2022 | $1,599,000 | +5230.0% | 48,299 | +9064.9% | 0.01% | – |
Q2 2021 | $30,000 | -59.5% | 527 | -46.7% | 0.00% | – |
Q1 2021 | $74,000 | – | 988 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
Diametric Capital, LP | 19,393 | $626,000 | 0.46% |